- The US government is receiving surplus of the exchequer for three quarters accounting the healthcare fraud cases exposed by whistleblowers between 1987 and 2013
- Over half the whistleblower cases registered under the False Claims Act since 1987 were related to healthcare and pharmaceuticals, followed by cases related to the department of defence, which accounted for 16% and led to the recovery of just $2.7 billion.
- Around 2.6 billion was recovered in 2013 of this, the bulk was paid by Johnson & Johnson, about $2.2 billion, to resolve a whistleblower case alleging kickbacks and promotion of drugs for unapproved uses, which included the anti-psychotic drugs, Risperdal and Invega, as well as Natrecor, a drug used in certain heart diseases.
- The total number of fraud cases under the Act is divided into ‘qui tam’ cases and ‘non-qui tam’ cases are about Qui tam cases jumped from just 30 cases filed in 1987 to 635 cases in 2011, 652 in 2011 and 753 in 2013.
- Upto 2000, non-qui tam cases brought in recoveries totalling over $3.6 billion while qui tam cases raked in over $4 billion in penalties.
- Read at:http://epaperbeta.timesofindia.com/Article.aspx?eid=31806&articlexml=US-nets-biggest-penalties-for-fraud-from-healthcare-19052014014056
Exams Perspective: